EPA finally finished it’s peer review of results from the infamous Ramazzini Institute labs that test sick animals after pressure from industry that the lab’s practices were inappropriate. It will no longer rely on findings from this lab when it does IRIS reports. Immediately affected are dropping cancer findings for methanol, MTBE and ETBE. http://www.epa.gov/iris/ramazzini.htm It [...]
Posts Tagged ‘GLP’
EPA IRIS: Good Science Finally
Posted in Product Stewardship, tagged GLP, IRIS on March 13, 2012 | Leave a Comment »
EPA BPA Testing Advance Notice
Posted in TSCA, TSCA Reform, tagged action plans, BPA, EHS Strategies Inc., endocrine dispruptors, GLP on July 26, 2011 | Leave a Comment »
As follow on to its Chemical Action Plan on Bisphenol A (BPA), EPA published an Advance Notice of Proposed Rulemaking July 26, 2011, to develop environmental effects and exposure testing. EPA is not addressing human health effects in this notice as there is ongoing testing work already with other agencies. (See a pointed Trevor Butterworth [...]
Good Laboratory Practices & Data Quality
Posted in Product Stewardship, tagged EHS Strategies Inc., endocrine dispruptors, GLP on July 20, 2011 | 2 Comments »
Kind of ironic: Industry has submitted a petition to EPA to hold off on getting data on List 2 for the Endocrine Disruptor Screening Program (EDSP) until the Agency reviews and issues final guidance on how they are going to deal with the results they get on the first list of chemicals – especially if [...]
